Pneumonia/Meningitis Nosode Combination 9414
Active substance: ACONITUM NAPELLUS WHOLE, BRYONIA ALBA ROOT, GELSEMIUM SEMPERVIRENS ROOT, SODIUM CARBONATE, NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE ANTIGEN, STREPTOCOCCUS PYOGENES, SILICON DIOXIDE
LIQUID · ACONITUM NAPELLUS WHOLE 3 [hp_X]/29.5mL, BRYONIA ALBA ROOT 3 [hp_X]/29.5mL, GELSEMIUM SEMPERVIRENS ROOT 3 [hp_X]/29.5mL, SODIUM CARBONATE 3 [hp_X]/29.5mL, NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE ANTIGEN 12 [hp_X]/29.5mL, STREPTOCOCCUS PYOGENES 12 [hp_X]/29.5mL, SILICON DIOXIDE 12 [hp_X]/29.5mL
United StatesActive
Marketing holder: Professional Complementary Health Formulas
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ACONITUM NAPELLUS WHOLE · 3 [hp_X]/29.5mL
- BRYONIA ALBA ROOT · 3 [hp_X]/29.5mL
- GELSEMIUM SEMPERVIRENS ROOT · 3 [hp_X]/29.5mL
- SODIUM CARBONATE · 3 [hp_X]/29.5mL
- NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE ANTIGEN · 12 [hp_X]/29.5mL
- STREPTOCOCCUS PYOGENES · 12 [hp_X]/29.5mL
- SILICON DIOXIDE · 12 [hp_X]/29.5mL
Registration
- Registration number
- 63083-9414
- Registration status
- Active
- Dispensing
- Over the counter
- Route
- ORAL
Sources
- product · openFDA NDC · 63083-9414 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 63083-9414 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 63083-9414 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 63083-9414 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 63083-9414 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 63083-9414 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 63083-9414 · Verified 2026-10-09 · open in source
- ingredients.5 · openFDA NDC · 63083-9414 · Verified 2026-10-09 · open in source
- ingredients.6 · openFDA NDC · 63083-9414 · Verified 2026-10-09 · open in source